rs74315305
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000396.4(CTSK):c.236G>A(p.Gly79Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G79R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000396.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSK | NM_000396.4 | c.236G>A | p.Gly79Glu | missense_variant | 3/8 | ENST00000271651.8 | NP_000387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSK | ENST00000271651.8 | c.236G>A | p.Gly79Glu | missense_variant | 3/8 | 1 | NM_000396.4 | ENSP00000271651.3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Pyknodysostosis Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 23, 2024 | Variant summary: CTSK c.236G>A (p.Gly79Glu) results in a non-conservative amino acid change located in the Cathepsin propeptide inhibitor domain (IPR013201) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251314 control chromosomes. c.236G>A has been reported in the literature in individuals affected with Pyknodysostosis (examples: Haagerup_2000, Ho_1999, Hou_1999, Sait_2021). These data indicate that the variant is likely to be associated with disease. Multiple publications report experimental evidence evaluating an impact on protein function (Hou_1999, Roy_2018). The most pronounced variant effect results in the absence of protease activity. The following publications have been ascertained in the context of this evaluation (PMID: 10878663, 10491211, 10074491, 30199612, 33945887). ClinVar contains an entry for this variant (Variation ID: 8424). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Aug 03, 2023 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 01, 1999 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at